Companies who receive scientific advice from our NICE Advice service may experience a faster path to guidance publication, a study has found. The research, which will be presented to delegates at the ...

Are you facing challenges in quickly bringing new healthtech products to market? The NHS is a large and complex system and ...

We use tools such as Google Analytics, Hotjar, Google Optimize and Loop11 to help us anonymously measure how you use our websites. This allows us to make improvements based on our users' needs.

The London School of Economics and Political Science (LSE) have joined forces with NICE to offer a unique solution - the Executive MSc in Healthcare Decision-Making.

We have also today published a new discussion aid to support shared decision making about HRT, focusing on the key risks and benefits to consider. The guideline clarifies that whilst HRT has some ...

Reason for decision Anticipate the topic will be of importance to patients, carers, professionals, commissioners and the health of the public to ensure clinical benefit is realised, inequalities in ...

A list of downloadable documents created during development.

Suggested remit: To appraise the clinical and cost effectiveness of darolutamide with androgen deprivation therapy within its marketing authorisation for treating hormone-sensitive metastatic prostate ...

Please note that following on from information provided to NICE by the company in January 2023, the appraisal was suspended from NICE’s work programme. As no further information has been received from ...

you can comment on draft recommendations the final recommendations are published published guidance is being reviewed. We'll use the information you provide on this form to contact you about the ...

A list of downloadable documents created during development.

All NICE products on COVID-19. Includes any guidance and advice.